Clinical Trial Update: N. Meningitidis Carriage Study

View source ↗

Summary

Neisseria meningitidis carriage study (NCT01808365) has completed. Sponsor: GlaxoSmithKline.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Infections

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Meningococcal | Status: COMPLETED